PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443363
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443363
Cell and Tissue Culture Supplies Market size was valued at USD 34,340.19 Million in 2023, expanding at a CAGR of 12.8% from 2024 to 2032.
Supplies for cell and tissue culture find applications in the fields of biotechnology, cell therapy, and regenerative medicine. The successful cultivation of plant cells and tissues relies on the use of high-quality and reliable culture media. Various instruments essential for cell and tissue culturing include plates, flasks, culture bags, pipetting instruments, incubators, cryostorage equipment, biosafety cabinets, and others.
Cell and Tissue Culture Supplies Market- Market Dynamics
Increasing research and development in cell and tissue engineering to propel market demand
The global growth of the cell and tissue culture supplies market is anticipated to be propelled by increasing research and development in cell and tissue engineering during the forecast period. On March 17, 2020, investigators at Seoul National University proposed a method to model biomechanical-stimuli-induced artery compression in vitro using a polydimethylsiloxane (PDMS) microfluidic 3D microvascular tissue cultivation structure that includes an integrated pneumatically actuated the compression mechanism. The device successfully cultured 3D microvascular tissues. The market is also expected to witness growth due to the increasing launch of new products aimed at enhancing the efficiency of the tissue culture process. For instance, on March 11, 2022, Cellink AB, a biotechnology company based in Sweden, introduced the BIO CELLX platform. This novel biodispensing tool automates 3D cell culture workflows by utilizing pre-validated protocols. BIO CELLX combines established technology, such as the proprietary clean chamber, with a novel way for easily combining hydrogels and cells, high precision dispensing, and automated nozzle priming to develop a system for repeatable and high-throughput model creation.
Cell and Tissue Culture Supplies Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2024-2032)
Based on Product type segmentation, consumable products was predicted to show maximum market share in the year 2023
Based on application segmentation, biopharmaceutical production was the leading type in 2023
On the basis of region, Asia Pacific was the leading revenue generator in 2023
The Global Cell and Tissue Culture Supplies Market is segmented on the basis of Product type, Application and Region.
The market is divided into two categories based on Product type: consumable products and instruments based on product type. The consumable products segment is expected to dominate the market due to the increasing introduction of new products.
The market is divided into seven categories based on application: biopharmaceutical production, vaccine production, drug screening and development, gene therapy, toxicity testing, cancer research, and others. Among these, the biopharmaceutical production segment is anticipated to lead the market over the forecast period, driven by the rising research activities in biopharmaceutical companies.
Cell and Tissue Culture Supplies Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
The Cell and Tissue Culture Supplies Market is undergoing strategic transformations to cater to the evolving needs of researchers and biopharmaceutical companies. Companies are directing their efforts towards the development of advanced and specialized cell culture products, particularly for applications like drug discovery and regenerative medicine. A noteworthy trend involves a shift towards creating innovative culture media formulations, serum alternatives, and surface treatments aimed at optimizing cell growth and enhancing performance. Single-use technologies are gaining traction in bioprocessing due to their efficiency and contamination control benefits. Sustainability is becoming an increasingly important consideration, prompting initiatives to introduce eco-friendly materials. Market players are expanding their product portfolios through acquisitions and collaborations to provide comprehensive solutions. With the growing significance of advanced therapies, there is an increasing demand for specialized culture supplies customized for cell-based and gene therapies.The cell and tissue culture supplies market is characterized by a focus on innovation, sustainability, and strategic collaborations to address the diverse needs of the life sciences industry.
In January 2022, BioIVT LLC, a U.S.-based biotechnology company, introduced good manufacturing practices grade human AB serum specifically designed for the development and manufacturing of cell and gene therapies.
GLOBAL CELL AND TISSUE CULTURE SUPPLIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Becton, Dickinson and Company
Merck KGaA
Corning, Inc.
Lonza Group
Eppendorf AG
Thermo Fisher Scientific, Inc.
Affymetrix, Inc.
GE Healthcare
VWR International, LLC
WHEATON Industries, Inc.
Others